It is possible that delaying a booster vaccination in a tumor-bearing mouse by 2 weeks failed because tumor burden was much too large by this time-point and that CD8+ T cell cytotoxicity was impaired by tumor-suppressive mechanisms, highlighting the requirement not only for robust anti-tumor immune responses but also combinatorial approaches to mitigate tumor-mediated immunosuppression. Here, CD8A is linked to neoplasm.